Indivior (LON:INDV) Shares Down 15.7% – What’s Next?

Indivior PLC (LON:INDV)’s stock price traded down 15.7% during mid-day trading on Friday . The stock traded as low as GBX 548.71 ($6.93) and last traded at GBX 732 ($9.25). 1,888,371 shares traded hands during mid-day trading, an increase of 166% from the average session volume of 709,477 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 1,800 ($22.74) price target on shares of Indivior in a report on Tuesday, December 17th.

Indivior Stock Down 5.9 %

The stock has a market capitalization of £1.08 billion, a P/E ratio of -570.87, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The stock’s 50 day simple moving average is GBX 920.11 and its 200 day simple moving average is GBX 849.69.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.